In silico trials using Monte Carlo simulation to evaluate ciprofloxacin and levofloxacin dosing in critically ill patients receiving prolonged intermittent renal replacement therapy
Crossref DOI link: https://doi.org/10.1186/s41100-016-0055-x
Published Online: 2016-09-07
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lewis, Susan J.
Chaijamorn, Weerachai
Shaw, Alexander R.
Mueller, Bruce A.
Funding for this research was provided by:
NxStage Medical Inc
